Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

COVID-19 Outcomes in Patients with Rheumatic Disease

  |  

Conclusion

These findings indicate that COVID-19 patients with systemic ARDs may be at a higher risk of hospitalization, ICU admission, acute renal failure and venous thromboembolism than matched comparators. These risks may be largely mediated by comorbidities, except for the risk of venous thromboembolism. Patients with a systemic rheumatic disease and COVID-19 should be closely monitored for thrombotic complications.

Refer to the full study for all source material. 

ADVERTISEMENT
SCROLL TO CONTINUE

Excerpted and adapted from: D’Silva KM, Jorge A, Cohen A, et al. COVID-19 outcomes in patients with systemic autoimmune rheumatic diseases compared to the general population: A U.S. multicenter, comparative cohort study. Arthritis Rheumatol. 2021 Jun;73(6):914­­–920.

Related Articles
    Antiphospholipid Syndrome: The Risk of Travel at High Altitudes

    Antiphospholipid Syndrome: The Risk of Travel at High Altitudes

    Antiphospholipid syndrome (APS) is an autoimmune clotting disorder that may present catastrophically with multiple thromboses over a short period of time. In this article, we examine the case of a woman with undiagnosed APS whose first symptoms presented during a long-haul flight. A review of the literature on thrombosis at high altitudes and during long…

    Weight Change in Early RA & the Risk of Mortality

    Sparks et al set out to investigate whether weight change during the early RA period is associated with subsequent mortality and to evaluate whether there is an RA-specific effect. They investigated weight change during the early RA period, because this is the window of time during which weight change is most likely to be related to RA-specific processes. They found that severe weight loss during the early RA period was associated with a subsequent increased mortality risk both for women with and without RA…